Pharmaceutical Executive February 13, 2025
In this Pharmaceutical Executive video interview, Edoardo Madussi, Head of Business Development, Intelligencia AI ponders the next big developments and breakthroughs he expects to see in the application of large language models.
In this interview, Edoardo Madussi, Head of Business Development, Intelligencia AI discusses the potential impact of AI-driven drug discovery platforms like DeepSeek and Qwen, highlighting their democratizing potential while also acknowledging challenges related to data quality and validation. The conversation explores the potential disruptions to current R&D practices, including the acceleration of drug discovery and the optimization of manufacturing and supply chains.
The discussion also addresses the potential risks associated with relying heavily on open-access AI models, including data security, intellectual property concerns, and the potential for biases...
Today's Sponsors
Today's Sponsor